Coloplast AS

Invested through
  • Triodos Impact Mixed Fund - Defensive
  • Triodos Impact Mixed Fund - Neutral
  • Triodos Impact Mixed Fund - Offensive
  • Triodos Euro Bond Impact Fund
  • Triodos Multi Impact Fund
  • Triodos Impact Strategy Fund - Defensive
  • Triodos Impact Strategy Fund - Balanced
  • Triodos Impact Strategy Fund - Offensive
Asset ClassesCorporate bonds
Impact strategyImpact Equities and Bonds
ISIN codeXS2481288525
Industry groupHealth Care Equipment & Services
Aligned with SDGs
  • Good health and well-being

Founded in 1957, Coloplast specialises in intimate healthcare. Its products and services make life easier for people with very personal and private medical conditions. The company operates in four business areas. Ostomy Care products and accessories are designed for people with a stoma, aiming to help reduce leakage and promote healthy skin. Continence Care helps people who are unable to empty their bladder or bowel, and people suffering from incontinence, to better manage their condition. Wound & Skin Care’s creams and dressings help chronic wounds heal. Urology Care includes implants and disposable devices that are used for the treatment of urological and gynaecological diseases.

Investment rationale

Coloplast develops products and services that make life easier for people with intimate healthcare needs. This requires both an understanding of their medical challenges and other concerns that impact their lives. These can be related to social situations, travel, work, intimacy, exercise or just a trip to the shops. It gains this understanding by listening to them and to nurses and specialists who care for them. Vision and mission focus on the quality of life, in line with the Triodos mission, and products contribute to social inclusion of patients with intimate health problems.